LevitasBio: Paul Steinberg and Joseph Walthers
LevitasBio, a Stanford University spinout, has appointed Paul Steinberg as chief commercial officer and Joseph Walthers as VP of finance.
Steinberg will lead LevitasBio's commercial roadmap and strategy and manage commercial functions at the firm. He was most recently VP of worldwide sales at NanoString Technologies and has held leadership roles in commercialization and business development at Fluidigm and Thermo Fisher Scientific, respectively. He holds a master's degree in analytical chemistry from the University of Miami.
Walthers will be responsible for financial planning, budgeting, accounting, risk management, and internal controls activities. He has over 20 years experience at life science and biotech companies including Twist Bioscience, Natera, and Rainin Instrument. He is a licensed CPA in California.